**Core Concept**
Peripheral neuropathy is a common side effect of antiretroviral therapy in HIV/AIDS patients, primarily due to mitochondrial toxicity. This condition results from the inhibition of mitochondrial DNA polymerase gamma by certain antiretroviral drugs, leading to decreased energy production and subsequent neuronal damage.

**Why the Correct Answer is Right**
The correct answer is one of the antiretroviral drugs that does not cause peripheral neuropathy by inhibiting mitochondrial DNA polymerase gamma. This is because it either works through a different mechanism or is less likely to cause mitochondrial toxicity.

**Why Each Wrong Option is Incorrect**
**Option A:** This antiretroviral drug is known to cause peripheral neuropathy due to its mitochondrial toxicity. It inhibits mitochondrial DNA polymerase gamma, leading to decreased energy production in neurons.
**Option B:** This antiretroviral drug is also associated with peripheral neuropathy, likely due to its mitochondrial toxicity. It may inhibit mitochondrial DNA replication or interfere with energy production in neurons.
**Option C:** This antiretroviral drug is less likely to cause peripheral neuropathy compared to the other options. It works through a different mechanism, such as inhibiting viral replication through a different target.

**Clinical Pearl / High-Yield Fact**
It's essential to note that not all antiretroviral drugs are created equal, and their side effect profiles can vary significantly. Clinicians should be aware of the specific side effects associated with each drug and monitor patients accordingly.

**Correct Answer: C. This antiretroviral drug is less likely to cause peripheral neuropathy compared to the other options. It works through a different mechanism, such as inhibiting viral replication through a different target.**